Team CZ - ACCRU

RU051417I

Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide (R2-ICE) [...]

RU051417ITeam CZ2022-07-14T17:54:24+00:00

A Randomized Phase 2 Non-inferiority Trial of (Z) - endoxifen [...]

ATOS-Z-201Team CZ2023-02-24T17:09:25+00:00

A Phase II, Open Label Study of Tucatinib Combined With [...]

SGNTUC-017_ACCRU-GI-1617Team CZ2022-07-21T18:58:29+00:00

Randomized Double-Blind Phase II Study of Radioactive Iodine (RAI) in [...]

RU241306ITeam CZ2022-07-14T17:49:35+00:00

Phase II, Multi- center Trial of Nivolumab and Brentuximab Vedotin [...]

RU051505ITeam CZ2022-07-14T17:48:14+00:00

A Multicenter Phase II Study of Pembrolizumab (MK-3475) in Patients [...]

RU021502ITeam CZ2022-07-14T17:46:33+00:00

BACCI: A Phase II Randomized, Double-Blind, Placebo- Controlled Study of [...]

RU021416ITeam CZ2022-07-14T17:44:31+00:00

Regorafenib Dose Optimization Study (ReDOS): A Phase II Randomized Study [...]

RU021407ITeam CZ2022-07-14T17:43:16+00:00

A Randomized Phase III Trial of Eribulin Compared to Standard [...]

RU011201ITeam CZ2022-07-14T17:41:26+00:00

A Phase II Single-Arm Study to Investigate Tepotinib Combined with [...]

MS202202-0002Team CZ2022-07-14T17:39:56+00:00